vehicle
Showing 51 - 75 of 264
Atopic Dermatitis Trial in United States (ATI-1777 2.0% w/w, ATI-1777 1.0% w/w, ATI-1777 0.5% w/w)
Recruiting
- Atopic Dermatitis
- ATI-1777 2.0% w/w
- +3 more
-
Birmingham, Alabama
- +25 more
Jun 20, 2022
Osteoarthritis, Knee Trial in Canada (G001 Topical Gel, Vehicle)
Recruiting
- Osteoarthritis, Knee
- G001 Topical Gel
- Vehicle
-
Brampton, Canada
- +9 more
Aug 9, 2021
Atopic Dermatitis Trial in China (SHR0302 Ointment, Vehicle)
Recruiting
- Atopic Dermatitis
- SHR0302 Ointment
- Vehicle
-
Beijing, Beijing, China
- +20 more
Jun 3, 2022
Varicose Veins Trial in United States (polidocanol injectable foam, 0.125%, polidocanol injectable foam, 0.5%, polidocanol
Completed
- Varicose Veins
- polidocanol injectable foam, 0.125%
- +3 more
-
Dothan, Alabama
- +11 more
Apr 19, 2021
Acne Scars, Wrinkles Trial in Chicago (Fibroblast Treatment, Vehicle)
Terminated
- Acne Scars
- Wrinkles
- Fibroblast Treatment
- Vehicle
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine, Department
Dec 2, 2021
Palmar Hyperhidrosis Trial in United States (Glycopyrronium cloth, 2.4%, Vehicle)
Completed
- Palmar Hyperhidrosis
- Glycopyrronium cloth, 2.4%
- Vehicle
-
Encinitas, California
- +6 more
Aug 23, 2021
Acute Fungal Otitis Externa Trial in United States (FST-201 (dexamethasone 0.1%) Otic Suspension, Vehicle)
Terminated
- Acute Fungal Otitis Externa
- FST-201 (dexamethasone 0.1%) Otic Suspension
- Vehicle
-
Boynton Beach, Florida
- +5 more
May 24, 2021
Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome Trial in Palo Alto (Sirolimus, 2%,
Completed
- Epidermolysis Bullosa Simplex
- +2 more
- Sirolimus, 2%
- Vehicle
-
Palo Alto, CaliforniaStanford University
Feb 25, 2022
Axillary Hyperhidrosis Trial in United States (Sofpironium Bromide, 15%, Vehicle)
Completed
- Axillary Hyperhidrosis
- Sofpironium Bromide, 15%
- Vehicle
-
Birmingham, Alabama
- +41 more
Dec 23, 2022
Hyperhidrosis Trial in United States (glycopyrronium Topical Wipes, Vehicle)
Completed
- Hyperhidrosis
- glycopyrronium Topical Wipes
- Vehicle
-
Rogers, Arkansas
- +19 more
Aug 23, 2021
Dry Eye Disease Trial in United States (AR 15512 Ophthalmic Solution, Vehicle)
Recruiting
- Dry Eye Disease
- AR 15512 Ophthalmic Solution
- Vehicle
-
Torrance, California
- +19 more
Dec 9, 2022
Glaucoma Trial in Palo Alto (rhNGF, Vehicle)
Completed
- Glaucoma
- rhNGF
- Vehicle
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
Nov 24, 2020
Presbyopia Trial in Andover (Aceclidine+tropicamide combination, Aceclidine, Vehicle)
Completed
- Presbyopia
- Aceclidine+tropicamide combination
- +2 more
-
Andover, MassachusettsAndover Eye Associates
Apr 19, 2021
Hyperhidrosis Trial in Canada, United States (Dose 1 of glycopyrrolate, 2.0% QD, Dose 2 of glycopyrrolate, 3.0% QD, Dose 1 of
Completed
- Hyperhidrosis
- Dose 1 of glycopyrrolate, 2.0% QD
- +4 more
-
Encinitas, California
- +14 more
Aug 23, 2021
Dry Eye Disease Trial in Québec (Palovarotene, Vehicle)
Completed
- Dry Eye Disease
- Palovarotene
- Vehicle
-
Québec, CanadaAlgorithme Pharma facility
Feb 18, 2021